Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorObafemi Awolowo University Teaching Hospital

About this trial

This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage.

Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Questionnaire
  • Bioimpedance/Body Composition Unit

Treatment groups

800 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Obafemi Awolowo University Teaching Hospital

Lead sponsor

Memorial Sloan Kettering Cancer Center

Collaborator

Lagos State University

Collaborator

University of Ilorin Teaching Hospital

Collaborator

Federal Medical Centre, Owo

Collaborator

University of Maiduguri Teaching Hospital

Collaborator

National Hospital, Abuja

Collaborator